This article was originally published in The Rose Sheet
Executive SummaryThe market for cosmeceuticals sold across mass, department, specialty and other retailers in the U.S. was estimated to be around $500 mil.-$600 mil. in 2005, according to Karen Young, president of marketing firm The Young Group. Exec presented during the Strategic Research Institute-sponsored Cosmeceuticals meeting in New York City June 8-9. In her presentation "Getting Your Brand Into the Channels That Count," Young noted the Internet remains an excellent means to attract new customers to a brand, and 80% of consumers regularly or occasionally purchase products online...
You may also be interested in...
The Coronavirus outbreak makes its first dent into pharma's 2020 prospects as AstraZeneca admits possible impact, while could AbbVie's aesthetic plans raise the prospect of another GSK-style spin off?
French off-patent industry association Gemme has declared a “state of emergency” for French generics as it revealed industry data for 2019 pointing to weak growth. Meanwhile, Gemme says, the country’s biosimilars market is “dynamic” and growing quickly but is still under-performing.
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.